Common Names
Geographic Range: Southern and Eastern Africa — South Africa, Mozambique, Zimbabwe.
Known Contraindications
1
Compounds
1
Traditions
1
Treatments
2
Conditions
OC[C@H]1OC(O[C@@H]2C=CC(=C/C=C/c3ccc(O)cc3)\CC2)[C@H](O)[C@@H](O)[C@@H]1OCYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | no significant interaction |
| CYP2C9 | weak interaction (rooperol metabolite) |
| CYP2D6 | no significant interaction |
| CYP3A4 | no significant interaction (parent compound) |
| CYP2C19 | no significant interaction |
| clinical_note | Limited CYP interaction data. Caution with immunomodulatory drugs due to immune-enhancing properties. |
| activation_note | Primary activation via beta-glucosidase (gut), not CYP. Rooperol undergoes hepatic glucuronidation and sulfation. |